Goldman Sachs Group Inc Kodiak Sciences Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 318,797 shares of KOD stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
318,797
Previous 318,229 0.18%
Holding current value
$2.05 Million
Previous $747,000 11.38%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$2.2 - $3.25 $1,249 - $1,846
568 Added 0.18%
318,797 $832,000
Q2 2024

Aug 13, 2024
SELL
$2.29 - $4.48 $78,434 - $153,444
-34,251 Reduced 9.72%
318,229 $747,000
Q1 2024

May 15, 2024
SELL
$3.01 - $7.45 $123,530 - $305,748
-41,040 Reduced 10.43%
352,480 $1.85 Million
Q4 2023

Feb 13, 2024
SELL
$1.4 - $3.24 $58,202 - $134,696
-41,573 Reduced 9.55%
393,520 $1.2 Million
Q3 2023

May 14, 2024
BUY
$1.8 - $7.49 $74,831 - $311,381
41,573 Added 10.56%
435,093 $783,000
Q3 2023

Nov 14, 2023
SELL
$1.8 - $7.49 $126,907 - $528,074
-70,504 Reduced 13.94%
435,093 $783,000
Q2 2023

May 14, 2024
BUY
$4.3 - $9.48 $443,123 - $976,932
103,052 Added 25.6%
505,597 $3.49 Million
Q2 2023

Aug 14, 2023
BUY
$4.3 - $9.48 $443,123 - $976,932
103,052 Added 25.6%
505,597 $3.49 Million
Q1 2023

May 14, 2024
SELL
$4.81 - $8.88 $122,731 - $226,582
-25,516 Reduced 5.96%
402,545 $2.5 Million
Q1 2023

May 11, 2023
SELL
$4.81 - $8.88 $122,731 - $226,582
-25,516 Reduced 5.96%
402,545 $2.5 Million
Q4 2022

May 14, 2024
SELL
$6.52 - $8.05 $245,373 - $302,953
-37,634 Reduced 8.08%
428,061 $3.06 Million
Q4 2022

Feb 13, 2023
SELL
$6.52 - $8.05 $245,373 - $302,953
-37,634 Reduced 8.08%
428,061 $3.06 Million
Q3 2022

May 14, 2024
BUY
$7.57 - $12.5 $1.58 Million - $2.6 Million
208,327 Added 80.95%
465,695 $3.6 Million
Q3 2022

Nov 10, 2022
BUY
$7.57 - $12.5 $1.58 Million - $2.6 Million
208,327 Added 80.95%
465,695 $3.6 Million
Q2 2022

May 14, 2024
SELL
$5.04 - $9.48 $686,206 - $1.29 Million
-136,152 Reduced 34.6%
257,368 $1.97 Million
Q2 2022

Aug 15, 2022
SELL
$5.04 - $9.48 $1.25 Million - $2.36 Million
-248,917 Reduced 49.17%
257,368 $1.97 Million
Q1 2022

May 16, 2022
BUY
$7.09 - $89.45 $1.2 Million - $15.1 Million
169,130 Added 50.16%
506,285 $3.91 Million
Q4 2021

Feb 14, 2022
SELL
$80.85 - $128.49 $5.26 Million - $8.36 Million
-65,060 Reduced 16.18%
337,155 $28.6 Million
Q3 2021

Nov 10, 2021
BUY
$81.97 - $106.94 $33 Million - $43 Million
402,215 New
402,215 $38.6 Million

Others Institutions Holding KOD

# of Institutions
98
Shares Held
39M
Call Options Held
6.5K
Put Options Held
5.8K
View Full List

About Kodiak Sciences Inc.

KOD Quotes by TradingView
  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $335M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email